Enhancement of NETosis by ACE2-cross-reactive anti-SARS-CoV-2 RBD antibodies in patients with COVID-19.
Saved in:
| Title: | Enhancement of NETosis by ACE2-cross-reactive anti-SARS-CoV-2 RBD antibodies in patients with COVID-19. |
|---|---|
| Authors: | Hsieh KH; Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Chao CH; Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Department of Medical Laboratory and Regenerative Medicine, MacKay Medical College, New Taipei, Taiwan., Cheng YL; Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Lai YC; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, 92037, USA.; Division of Infectious Diseases, Department of Medicine, University of California, San Diego, La Jolla, CA, 92037, USA., Chuang YC; Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Leadgene Biomedical, Inc, Tainan, Taiwan.; Department of Biomedical Sciences, Chung Shan Medical University, Taichung, Taiwan., Wang JR; Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Diseases and Vaccinology, National Institute of Infectious National Health Research Institutes, Tainan, Taiwan.; Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan., Chang SY; Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Hung YP; Department of Internal Medicine, Tainan Hospital, Ministry of Health and Welfare, Tainan, Taiwan.; Department of Internal Medicine, National Cheng Kung University, Medical College and Hospital, Tainan, Taiwan., Chen YA; Laboratory of Important Infectious Diseases and Cancer, Department of Medicine, School of Medicine, Fu Jen Catholic University, New Taipei City, 242, Taiwan.; School of Medicine, Fu Jen Catholic University, New Taipei City, 242, Taiwan.; Diseases and Vaccinology, National Institute of Infectious National Health Research Institutes, Miaoli County, 350, Taiwan., Liu WL; School of Medicine, Fu Jen Catholic University, New Taipei City, 242, Taiwan.; Department of Critical Care Medicine, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei City, 243, Taiwan.; Data Science Center, College of Medicine, Fu Jen Catholic University, New Taipei City, 242, Taiwan., Chuang WJ; Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Yeh TM; Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan. today@mail.ncku.edu.tw.; Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan. today@mail.ncku.edu.tw. |
| Source: | Journal of biomedical science [J Biomed Sci] 2024 Apr 18; Vol. 31 (1), pp. 39. Date of Electronic Publication: 2024 Apr 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 9421567 Publication Model: Electronic Cited Medium: Internet ISSN: 1423-0127 (Electronic) Linking ISSN: 10217770 NLM ISO Abbreviation: J Biomed Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1423-0127 |
|---|---|
| DOI: | 10.1186/s12929-024-01026-5 |
